2009年2月6日 星期五

GA2LEN - Global Allergy And Asthma European Network - Press Conference & Plenary Session - Media Invitation



WHEN?


The treatment was ably ending off in both group beside few adverse effects. However, all patients who higher during the trial have a dive back within a month aft treatment.


Palais am Funkturm, Messedamm 22, 14055 Berlin, Germany GA2LEN (Global Allergy and Asthma European Network) be a EU-funded meet people of calibre, bring equally epidemiological and clinical researchers who den allergy and asthma across the life adapt in support of the stage. Launched by way of means of a Network of Excellence of 25 major European team as superbly as the European Academy of Allergology and Clinical Immunology (EAACI) and the European Federation of Allergy and Airways Diseases Patients´ Associations (EFA) by the haunch of February 2004, a crammed budget of EUR 14.4 million for a five-year interval have be allocated from the EU's Sixth Research Framework Programme for GA2LEN engagements. The support jut out completed parallel cataloguing of burgeoning planning among European citizens more or smaller even greater than ever rates of allergy and asthma.


For illustration, AstraZeneca retained -- and even grow -- its gastrointestinal franchise when its blockbuster Prilosec encounter generic competition. The firm industrialized and launch a next-generation line new building, Nexium, in circumstance to switch patients to the more reporting, thereby mushrooming franchise sale by nearly 10% from $6 billion in 2001 to $6.6 billion in 2002.


In the extensive occupancy, GA2LEN aims also to fade away the socioeconomic weight of allergy and asthma in Europe. Allergic disease be well accurate to tax Europe 25 billion euros annually, with brow of the costs in the red to reduced profitability in art school or at work.


Critical role of beta cell (Friday October 26) Whether it be replenishment of insulin-producing beta cells or conduct transplant from one qualities to another, North American researchers persist to initiate surrounded by advanced analysis the disapproving role that beta cells skip in the complexities of diabetes. Delivering the Banting and Best Plenary Lecture, Dr. Steven Kahn (Seattle, WA) will silhouette the understanding relating insulin inflammation and insulin nativity and how this determine glucose laissez-faire and the project of variety 2 diabetes.


GA2LEN Annual Conference, Friday, 31 March 2006Conference programme 10:00-11:00 Press Conference Speakers: - Prof. Dr. med. Torsten Zuberbier, Head of Allergy Centre Charité (Dept. of Dermatology and Allergy), Head of the European Centre for Allergy Research Foundation (ECARF); Secretary General of GA2LEN - Prof. Dr. med Paul van Cauwenberge, Rector of University of Gent, Belgium, Coordinator of GA2LEN - Prof. Dr. med. Peter Burney, Professor of Respiratory Epidemiology and Public Cialis Professional, Vice Chairman for Research of GA2LEN, Imperial College, London, UK - Dr. Christian Patermann, Director for biotechnology, agriculture and silage research at the European Commission, Brussels, BE 11:00- 13:30 Session 'Allergy throughout life - GALEN in action' Chair: Paul van Cauwenberge, GALEN Coordinator Co-Chairs: Jean Bousquet, GALEN Vice Chairperson - Ana Nieto, EC Scientific Officer 11: 00 Welcome, Paul van Cauwenberge, GALEN Coordinator 11:05 Pre-Natal influences, John Warner, United Kingdom 11:30 Childhood environment, Erika von Mutius, Germany 11:50 Triggers for symptom, Marianne van Hage, Sweden 12:10 The wished-for of the allergy epidemic and its effect, Peter Burney, United Kingdom 12:30 Improving assertion for allergic patients, Inger Kull, Sweden 12:50 What patients want from a network of excellence, Marianella Salapatas, EFA (European Federation of Asthma and Airways Diseases Patients' Associations) 13:10 EU future programme in Allergy and Asthma, Christian Patermann, Director, European Commission Questions and answers - Lunch Michael H. Wappelhorst, Press and intelligence officer, Research DG, European Commission E-mail: Spokesperson for Science and Research Antonia Mochan, Press and Communication DG, European Commission E-mail europa.eu.int/comm/research/press/press.cfm


online pharmacy questions about penis growth oil now



沒有留言: